MedTrace Logo

Impact of Insecticide Resistance on Vector Control

NCT01713517 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 28000

Last updated 2012-10-26

No results posted yet for this study

Summary

The purpose of the study is to determine whether long lasting insecticidal nets and indoor residual insecticide spraying, alone or in combination, are effective for controlling insecticide resistant anopheles mosquitoes for malaria prevention.

Conditions

  • Malaria, Falciparum

Interventions

OTHER

Indoor residual insecticide spraying (IRS)

Application of insecticide to interior walls of domiciliary structures to kill malaria vector mosquitoes which rest on walls after taking human blood meal

DEVICE

Long Lasting Insecticidal Nets (LLIN)

Provision of LLIN to all community members in the clusters allocated to the study arm. LLIN protect individuals from bites by malaria vector mosquitoes by providing a physical barrier and insecticidal and repellent effect.

Sponsors & Collaborators

  • Federal Ministry of Health, Sudan

    collaborator OTHER_GOV

  • World Health Organization

    collaborator OTHER

  • Liverpool School of Tropical Medicine

    collaborator OTHER

  • London School of Hygiene and Tropical Medicine

    lead OTHER

Principal Investigators

  • Immo Kleinschmidt, PhD · London School of Hygiene and Tropical Medicine

  • Martin J Donnelly, PhD · Liverpool School of Tropical Medicine

  • Khalid A Elmardi, MD · Federal Ministry of Health, Sudan

  • Hmooda T Kafy, MSc · Federal Ministry of Health, Sudan

  • Bashir A Ismail, MSc · Federal Ministry of Health, Sudan

  • Mohamed Ahmed A Mohamed, MSc · Federal Ministry of Health, Sudan

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • Sudan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01713517 on ClinicalTrials.gov